Get in touch!
We're here to help - feel free to reach out with any questions, thoughts, or requests, and we’ll get back to you as soon as we can.
DHEA: New Evidence in Fertility and Hormone Health
Dehydroepiandrosterone (DHEA) has long been recognised as a key precursor hormone, supporting the production of both androgens and oestrogens as we age. While many of DHEA’s established benefits, including energy, mood, and age-related hormone decline, are already well documented, recent clinical research has begun to shed light on two particularly compelling areas:
- Reproductive health and fertility outcomes
- Hormonal balance in postmenopausal women
These emerging findings help refine where DHEA supplementation may be most biologically relevant, and for whom it may offer the greatest potential benefit.
DHEA and Fertility: New Insights from Clinical Research
Interest in DHEA supplementation for fertility support has grown steadily over the past decade, particularly among women experiencing diminished ovarian reserve or age-related reproductive challenges. Recent research has expanded this discussion beyond ovarian function alone.
Supporting the Uterine Environment
A 2024–2025 systematic review and meta-analysis examining DHEA supplementation prior to IVF and ICSI treatment found that DHEA may:
- Increase endometrial thickness, an important factor for successful embryo implantation
- Improve several markers of oocyte and embryo quality
- Be associated with higher clinical pregnancy rates in specific subgroups, particularly women with thinner endometrial lining
These findings suggest that DHEA’s role in fertility may extend beyond egg quality, potentially supporting the uterine environment through improved hormonal signalling and tissue responsiveness.
What the Evidence Doesn’t Yet Show
Importantly, the same analysis found that:
- Improvements in live birth and ongoing pregnancy rates were not consistently demonstrated
- Overall evidence quality was rated as low to very low, highlighting the need for larger, well-designed trials
This positions DHEA as a potential adjunct rather than a standalone fertility intervention, best considered within a broader, medically guided reproductive strategy.
Safety Observations
Across the trials reviewed, no serious adverse effects were reported, reinforcing DHEA’s generally favourable short-term safety profile when used appropriately. However, researchers emphasise the importance of individualised dosing and clinical oversight.
Hormonal Balance in Postmenopausal Women: Clearer Dose-Dependent Effects
One of the most consistent physiological effects of DHEA supplementation is its ability to influence downstream hormone levels – a topic that has now been clarified by recent high-quality analyses.
Restoring Declining Hormones
A 2025 meta-analysis of randomised controlled trials found that DHEA supplementation in postmenopausal women:
- Significantly increased testosterone levels
- Significantly increased estradiol levels
- Produced the most consistent effects in women aged 60 and over
- Required doses of approximately 50 mg per day or higher to achieve measurable hormonal changes
Lower doses showed more variable results, helping explain why earlier studies produced mixed findings.
Why This Matters
Postmenopausal hormone decline is associated with changes in:
- Energy and vitality
- Bone density
- Skin and connective tissue health
- Libido and sexual wellbeing
By acting as a natural upstream precursor, DHEA allows the body to convert what it needs locally, rather than introducing a single exogenous hormone, a mechanism often described as more “physiological” than direct hormone replacement.
That said, this same conversion capacity is what makes dose and individual context critically important.
A Hormone Precursor, Not a Simple Supplement
These emerging findings reinforce an essential point: DHEA is biologically powerful.
Its effects vary depending on:
- Age
- Sex
- Baseline hormone levels
- Tissue-specific enzyme activity
While moderate supplementation may help restore declining hormone levels in some individuals, excessive or unsupervised use could theoretically contribute to unwanted hormonal effects – particularly in hormone-sensitive conditions.
What This Means for Thoughtful Supplementation
Taken together, the latest research suggests that DHEA supplementation may offer targeted benefits in specific populations:
- Women undergoing fertility treatment, particularly where endometrial or ovarian markers are suboptimal
- Postmenopausal women seeking to support age-related hormonal decline, under appropriate guidance
What it does not support is a one-size-fits-all approach or exaggerated anti-aging claims.
As research continues to evolve, DHEA remains a compound best approached with respect for its endocrine role, a clear understanding of dosing, and an appreciation for individual variation.
In Summary
- New fertility research suggests DHEA may improve endometrial thickness and certain pregnancy markers, though evidence for live birth outcomes remains limited
- Recent meta-analyses confirm that DHEA can meaningfully increase testosterone and estradiol levels in postmenopausal women, particularly at doses ≥50 mg
- Long-term safety and optimal dosing strategies continue to be areas of active research
When used thoughtfully, DHEA remains one of the most intriguing and complex supplements in the field of hormonal health.
Scientific References
1. Fertility / IVF Meta-Analysis
Huang L, Gao Y, Liang S, et al.
Administration of dehydroepiandrosterone improves endometrial thickness in women undergoing IVF/ICSI: a systematic review and meta-analysis.
Journal of Ovarian Research. 2025;18:35.
DOI: 10.1186/s13048-024-01581-3
View on PubMed
2. Postmenopausal Hormone Meta-Analysis
He S, Lu K, Zhang L, Cao H, Zhang X, Tang X.
Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects.
Diabetology & Metabolic Syndrome. 2025;17:258.
